$ENRT
Enertopia Corp.

2021 Form 10-K Financial Statement

#000106299321010561 Filed on November 10, 2021

View on sec.gov

Income Statement

Concept 2021 2020 2019 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $592.9K $150.1K $51.44K
YoY Change 295.14% -46.53% -35.7%
% of Gross Profit
Research & Development $20.45K $1.702K $1.030K
YoY Change 1101.53% -88.44%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $613.4K $170.1K $52.46K
YoY Change 260.52% -59.39% -34.43%
Operating Profit -$614.8K -$170.1K
YoY Change 261.35% -59.39%
Interest Expense $42.99K $1.651K -$3.490K
YoY Change 2503.88% 38.51%
% of Operating Profit
Other Income/Expense, Net $250.0K $19.85K
YoY Change 1159.38% -43.05%
Pretax Income -$389.4K $34.13K -$55.96K
YoY Change -1240.78% -108.08% -30.05%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$389.4K $34.13K -$55.96K
YoY Change -1240.77% -108.08% -30.05%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share -$2.888K $266.00 -$438.90
COMMON SHARES
Basic Shares Outstanding 134.8M shares
Diluted Shares Outstanding 134.8M shares

Balance Sheet

Concept 2021 2020 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $369.3K $69.88K $9.760K
YoY Change 428.45% 615.98% -94.58%
Cash & Equivalents $354.3K $45.53K $9.758K
Short-Term Investments $14.99K $24.35K
Other Short-Term Assets $41.26K $14.82K $30.26K
YoY Change 178.41% -51.02% -66.38%
Inventory
Prepaid Expenses $30.26K
Receivables $4.550K $1.510K $6.225K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $415.1K $86.21K $46.25K
YoY Change 381.5% 86.4% -82.87%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $415.1K $86.21K $46.25K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $415.1K $86.21K $46.25K
YoY Change 381.5% 86.4% -82.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $309.3K $290.3K $283.4K
YoY Change 6.52% 2.44% 1.23%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $15.48K
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $420.9K $479.2K $502.1K
YoY Change -12.15% -4.57% 11.58%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $420.9K $479.2K $502.1K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $420.9K $479.2K $502.1K
YoY Change -12.15% -4.57% 11.58%
SHAREHOLDERS EQUITY
Retained Earnings -$14.31M
YoY Change
Common Stock $127.5K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.840K -$393.0K -$455.9K
YoY Change
Total Liabilities & Shareholders Equity $415.1K $86.21K $46.25K
YoY Change 381.5% 86.4% -82.87%

Cashflow Statement

Concept 2021 2020 2019 Q3
OPERATING ACTIVITIES
Net Income -$389.4K $34.13K -$55.96K
YoY Change -1240.77% -108.08% -30.05%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$408.2K -$127.1K -$19.75K
YoY Change 221.14% -61.01% -60.5%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $307.2K $178.9K
YoY Change 71.75%
Cash From Investing Activities $307.2K $178.8K
YoY Change 71.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $409.8K -$15.97K 15.30K
YoY Change -2666.33% -110.02% -84.7%
NET CHANGE
Cash From Operating Activities -$408.2K -$127.1K -19.75K
Cash From Investing Activities $307.2K $178.8K
Cash From Financing Activities $409.8K -$15.97K 15.30K
Net Change In Cash $308.8K $35.77K -4.450K
YoY Change 763.18% -121.46% -108.9%
FREE CASH FLOW
Cash From Operating Activities -$408.2K -$127.1K -$19.75K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
000-51866
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1970188
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
17308 USD
CY2021Q3 us-gaap Marketable Securities
MarketableSecurities
14994 USD
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
#18 1873 SPALL RD
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
KELOWNA
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
COLUMBIA
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V1Y 4R2
CY2021 dei City Area Code
CityAreaCode
250
CY2021 dei Local Phone Number
LocalPhoneNumber
870-2219
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
111659 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
139213 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14524341 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-455885 USD
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11489 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
17308 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
34132 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-389368 USD
CY2021 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
69000 USD
CY2021 enrt Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
180000 USD
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
297691 USD
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3020000 shares
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
95992 USD
CY2021 enrt Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
2720000 shares
CY2021 enrt Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
133800 USD
CY2021 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
85338 USD
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
7042 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
1963 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
297691 USD
CY2021 us-gaap Communication
Communication
75 USD
CY2021 us-gaap Gain Loss On Investments
GainLossOnInvestments
53488 USD
CY2021 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-5680 USD
CY2021 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
69000 USD
CY2021 us-gaap Royalty Income Nonoperating
RoyaltyIncomeNonoperating
250000 USD
CY2021 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
53488 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
69000 USD
CY2021 enrt Income From Royalty Grant
IncomeFromRoyaltyGrant
250000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-408202 USD
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
74873 USD
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
17705 USD
CY2021 enrt Proceeds From Sale Of Royalty Grant
ProceedsFromSaleOfRoyaltyGrant
250000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
307168 USD
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
95992 USD
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
133800 USD
CY2020 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
15968 USD
CY2021 enrt Net Proceeds From Subscriptions Received
NetProceedsFromSubscriptionsReceived
180000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
409792 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15968 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
308758 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
35770 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
666 USD
CY2021 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-5841 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-left:54pt;margin-bottom:0pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>d.</strong><span style="width:9.94pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Accounting Estimates</strong></span></span></p> <p style="margin:0pt">&#160;</p> <p style="margin-top:0pt;margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of financial statements in conformity with U.S GAAP requires us to make certain estimates, judgements and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Some of the Company's accounting policies require us to make subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. These accounting policies involve critical accounting estimates because they are particularly dependent on estimates and assumptions made by management about matters that are highly uncertain at the time the accounting estimates are made. Although we have used our best estimates based on facts and circumstances available to us at the time, different estimates reasonably could have been used. Changes in the accounting estimates used by the Company are reasonably likely to occur from time to time, which may have a material effect on the presentation of financial condition and results of operations.</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company reviews these estimates, judgments and assumptions periodically and reflect the effects of revisions in the period in which they are deemed to be necessary. We believe that these estimates are reasonable; however, actual results could differ from these estimates.</span></span></p> <p style="text-indent:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Significant accounting estimates and assumptions are used for, but not limited to:</span></span></p> <p style="margin-left:90pt;margin-bottom:0pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a)<span style="width:10.23pt;text-indent:0pt;display:inline-block">&#160;</span>The Valuation of Deferred Tax Assets</span></span></p> <p style="margin-top:0pt;margin-left:72pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Judgement is required in determining whether deferred tax assets are recognized on the balance sheet. The recognition of deferred tax assets requires management to assess the likelihood that the Company will generate taxable income in future periods to utilize the deferred tax assets. Due to the Company's history of losses, deferred tax assets have not been recognized by the Company.</span></span></p> </div> <div> <p style="margin-left:90pt;margin-bottom:0pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b)<span style="width:9.67pt;text-indent:0pt;display:inline-block">&#160;</span>Value of Stock Options</span></span></p> <p style="margin-top:0pt;margin-left:72pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company provides compensation benefits to its employees, directors, officers, and consultants, through a stock option plan. The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model. Expected volatility assumption used in the model is based on the historical volatility of the Company's share price. The Company uses historical data to estimate the period of option exercises for use in the valuation model. The risk-free interest rate for the expected term of the option is based on the yields of government bonds. Changes in these assumptions, especially the share price volatility and the expected life determination could have a material impact on the Company's profit and loss for the periods presented. All estimates used in the model are based on historical data which may not be representative of future results.</span></span></p> </div>
CY2021Q3 us-gaap Share Price
SharePrice
0.0629
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3626776 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
128471700 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
139211700 shares
CY2020 enrt Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Estimated Fair Value Per Option
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEstimatedFairValuePerOption
0.01 USD
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:0pt;margin-left:54pt;margin-bottom:0pt;text-align:justify;text-indent:-18pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>l.</strong><span style="text-indent:0pt">&#160; &#160; &#160;</span><strong>Concentration of credit risk</strong></span></span></p> <p style="margin:0pt">&#160;</p> <p style="margin-top:0pt;margin-left:36pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company places its cash with high credit quality financial institution.</span></span></p> </div>
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
14994 USD
CY2021 enrt Payments To Acquire Marketable Securities Disposals Cost
PaymentsToAcquireMarketableSecuritiesDisposalsCost
-21385 USD
CY2021Q1 enrt Number Of Units Issued In Final Tranche Of Private Placement
NumberOfUnitsIssuedInFinalTrancheOfPrivatePlacement
3000000 shares
CY2021Q1 enrt Units Issue Price
UnitsIssuePrice
0.06
CY2021Q1 enrt Gross Proceeds Of Units Issued In Final Tranche Of Private Placement
GrossProceedsOfUnitsIssuedInFinalTrancheOfPrivatePlacement
180000 USD
CY2021Q1 enrt Description Of Units Issuance In Private Placement
DescriptionOfUnitsIssuanceInPrivatePlacement
Each unit consists of one common share of the Company and one half (0.5) of a non-transferable share purchase warrant, each warrant entitling the holder to purchase one additional common share of the Company for a period of 12 months from the date of issuance at a purchase price of $0.09.
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
139211700 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
128471700 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
5150000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9320000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10076776 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.07
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.06
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.08
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2000000 shares
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8320000 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.02
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.10
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1000000 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1100000 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.10
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.05
CY2021 enrt Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod
3293224 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.02
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.63 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0116 pure
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y4M24D
CY2021Q3 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
4526 USD
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
48589 USD
CY2021 enrt Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
-2300000 shares
CY2021 enrt Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price
ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice
0.05
CY2020 enrt Class Of Warrant Or Right Expirations In Period
ClassOfWarrantOrRightExpirationsInPeriod
12904590 shares
CY2020 enrt Class Of Warrant Or Right Expirations In Period Weighted Average Exercise Price
ClassOfWarrantOrRightExpirationsInPeriodWeightedAverageExercisePrice
0.07
CY2021 enrt Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
1500000 shares
CY2021 enrt Class Of Warrant Or Right Issued Per Share
ClassOfWarrantOrRightIssuedPerShare
0.09
CY2020Q3 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
4526 USD
CY2019Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
26141459 shares
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13236869 shares
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
9716869 shares
CY2019Q3 enrt Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.06
CY2020Q3 enrt Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.05
CY2021Q3 enrt Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.05
CY2021 enrt Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
2720000 shares
CY2021 enrt Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price
ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice
0.04
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.05
CY2021 enrt Rental Commitment
RentalCommitment
1100 USD
CY2021Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2837893 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-81767 USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7168 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
62515 USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
3635 USD
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
3952 USD
CY2020 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
4441 USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
15300 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-15244 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2795131 USD
CY2020Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2776534 USD
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2853193 USD
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2837893 USD
CY2021Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2020Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2021Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
13310000 USD
CY2020Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
13220000 USD
CY2021 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-389368 USD
CY2020 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-34132 USD
CY2020Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2853193 USD

Files In Submission

Name View Source Status
0001062993-21-010561-index-headers.html Edgar Link pending
0001062993-21-010561-index.html Edgar Link pending
0001062993-21-010561.txt Edgar Link pending
0001062993-21-010561-xbrl.zip Edgar Link pending
enrt-20210831.xml Edgar Link completed
enrt-20210831.xsd Edgar Link pending
enrt-20210831_cal.xml Edgar Link unprocessable
enrt-20210831_def.xml Edgar Link unprocessable
enrt-20210831_lab.xml Edgar Link unprocessable
enrt-20210831_pre.xml Edgar Link unprocessable
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10k.htm Edgar Link pending
form10kx001.jpg Edgar Link pending
form10kxu001.jpg Edgar Link pending
form10kxu002.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending